Table 2. Gender affirming hormone tratment prescribed: route of administration and medical compounds.
Parameter | n(%) | |
---|---|---|
GAHT route of administration | ||
Oral | 47(54.7) | |
Parenteral | 16(18.6) | |
Both | 23(26.7) | |
Medical compound | ||
Estrogen + cyproterone or spironolactone | 39(45.3) | |
Estrogen+progestogen | 17(19.8) | |
Estrogen only | 30(34.9) |
GAHT - gender affirming hormone treatment, values expressed in absolute number (percentages)